Navigation Links

Medicine News

Diversity Focus Announces Partnership with BlendCard

1/15/2014
(PRWEB) January 15, 2014 We live in a unique time where the concept “Buy Local” is becoming more and more important. Local businesses and even governments have looked for and established ways to promote the local economy. With that in mind, Diversity Focus is excited to announce a partnership with BlendCard. This collaboration enhances diversity and promotes inclusive communities by creatin... [Comments]

Kirk Manzo of The Manzo Group Announces New Affiliation with The John Maxwell Team

1/15/2014
Atlanta, GA (PRWEB) January 15, 2014 The Manzo Group, a sales training and consulting firm based in Atlanta, Ga., announces its affiliation with the John Maxwell Team for coaching, training and speaking on the areas of communication and leadership programs. With programs designed specifically for the automotive industry, the Manzo Group aims at attracting new and used car dealerships in... [Comments]

Dr. Leigh Ann Scott to Open Irving Office to Provide Bio-Identical Hormone Therapy

1/15/2014
Dallas, TX (PRWEB) January 15, 2014 Dr. Leigh Ann Scott has announced the opening of her new office in Irving to provide Bio-identical Hormone Replacement Therapy. “Bio-identical hormones are a vital treatment option and medical science supports their use in improving overall health while diminishing the effects of aging. Most patients are surprised at how helpful they can be as part of an... [Comments]

Dr. Yonatan Mahller Joins DoctorsElite as a New Member

1/15/2014
Gulfport, MS (PRWEB) January 15, 2014 DoctorsElite, a site that helps patients around the United States locate doctors by diagnosis, treatment, and specialty, has announced the addition of Dr. Yonatan Mahller to their growing physician membership. Dr. Mahller's expertise in OB/GYN medicine is a welcome addition to the site's ranks of medical specialists. Dr. Yonatan Mahller was... [Comments]

Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'

1/15/2014
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advan... [Comments]Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'

Resisting the flu

1/15/2014
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since u... [Comments]Resisting the flu

Nationwide minimally invasive surgery rates triple for pancreatic disease

1/15/2014
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend... [Comments]Nationwide minimally invasive surgery rates triple for pancreatic disease

Iskream is Proud to Announce a Partnership with HMA-Hearst Media Agency

1/15/2014
Milford, CT (PRWEB) January 15, 2014 Iskream is proud to announce a partnership with Hearst Media Agency. As part of the campaign, Hearst will develop and distribute news content in the form of frequent press releases through the largest online PR channel in the world. Iskream is a low-fat, gluten-free , no-sugar-added ice cream made with stevia. Iskream engaged Hearst Media Services t... [Comments]

Medicine Products

Osteomesh Bioresorbable Implant for Craniofacial Surgery

Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...
Company:Osteopore International

AMD Now

Description:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN

SWISSBLADE Diamond Surgical Knives

Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...
Company:ZIEMER USA, Inc.

MAXWELL Optical Wavefront Aberrometer

Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...
Company:ZIEMER USA, Inc.

ConstaVac CBCII Blood Conservation System

Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....
Company:Stryker Instruments

Medicine Technology

Sono-Tek Announces Third Quarter Results

1/15/2014
MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  $2,650,000 for the three months ended November 30, 2013, compared to sales of $2,202,000 for the prior year period, an increase of $448,000 or 20%. Once again, this quarter has also shown growth over the preceding quarter's sales, continuing a trend that began in the first quarter o... [Comments]

Orthopedic Instrument Industry in China Markets Forecast to 2015

1/15/2014
DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research report to its store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the ye... [Comments]

Mission Pharmacal Conducts Online Survey of Osteoporosis Patients

1/15/2014
SAN ANTONIO , Jan. 15, 2014 Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in a... [Comments]

Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018

1/15/2014
DUBLIN , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of the "Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables are product... [Comments]

Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest

1/15/2014
GRAND RAPIDS, Mich. , Jan. 15, 2014 As health officials across the Midwest warn against the widespread reach of the flu virus, select Meijer pharmacies in Michigan will offer free diagnostic testing for influenza and strep throat to eligible patients, enabling Meijer pharmacists to administer tests and, in some cases, fill the matching prescriptions, under strict protocol... [Comments]

(Date:4/18/2014)... The Gerontologist reports that among ... a decrease in anxiety about death and increases in ... lives. In particular, listening to gospel music is associated ... increase in sense of control. , These associations are ... individuals of both low- and high-socioeconomic status. , The ...
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... , , , MANHATTAN, Kan., ... work of a K-State researcher are making headway in the effort ... Juergen Richt is a Regents Distinguished Professor at K-State,s College of ... work at K-State and with outside collaborators is revealing the characteristics ...
... Experts urge parents to get their kids, eyes checked regularly ... percent of kids aged 12 to 17 have trouble seeing ... the nearly 1,500 children in the survey, more than 25 ... though 45 percent of them wore some type of prescription ...
... , CHESTNUT HILL, Mass., Aug. 3 SkinCare ... live Artefill patient demonstration at the American Academy of Dermatology Summer ... collagen filler for the correction of smile lines and was one ... 31st. , , "Over the past several years ...
... , ALLEGAN, Mich., Aug. 3 Perrigo Company (Nasdaq: ... Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories ... Administration to market Triamcinolone Acetonide Nasal Spray containing a paragraph IV ... complete ANDA with a Paragraph IV certification for NASACORT AQ. The ...
... equipment alone is responsible for an increased number of ... to a study performed at San Luis Diagnostic Center ... that there was a significant increase in the number ... to digital mammography. The number of cancers detected prior ...
... in French . Heavy drinkers of ... cancer than the population at large, says a group of ... in the highest consumption category increased their risk of developing ... cancer by 50%. In all, the researchers found ...
Cached Medicine News:Health News:K-State Researcher, Collaborators Study Virulence of Pandemic H1N1 Virus; Work at K-State Would Protect Pig Industry If the Virus Jumps to Swine Populations 2Health News:Leading Boston Dermatologist Performs Live Artefill Patient Demonstration at American Academy of Dermatology Summer Meeting 2Health News:Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ 2Health News:Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ 3Health News:Heavy drinkers face significantly increased cancer risk 2
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... Sledge Microtome is ideal for sectioning of specimens ... Specimen rise is automatic and accurate with ... in increments of 2 microns. Will accommodate ... Vibratomes Freezing Stages , ...
... The Professional Gold Package ... your laboratory. The package includes ... and automated system, starter package ... v-block adapter, specimen mounts 1/2" ...
Medicine Products:
(Date:1/15/2014)... The Cadence Fitness & Health Center has been certified ... Association, a non-profit organization assisting medically integrated health and ... Fitness & Health Center is the only certified fitness ... Chicagoland area. "The certification means the Cadence ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... PHOENIX, Sept. 4 Zila, Inc.,s (Nasdaq: ZILA ... of,abnormalities which can lead to oral cancer, has been ... of Cetuximab (ERBITUX(R)), a,leading cancer therapeutic for head and ... and distributed by Bristol-Meyers Squibb (NYSE:,BMY). The NIH ...
... Meets Primary and All Secondary Endpoints, San ... NGSX ), a biopharmaceutical company focused on developing ... from,its second pivotal study of NGX-4010, the Company,s ... -- in patients with postherpetic,neuralgia (PHN). The study, ...
Cached Medicine Technology:Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 2NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 3NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 4NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 5NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 6NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 7

Microsoft VBScript runtime error '800a01f4'

Variable is undefined: 'fe'

/inc/ab_right.asp, line 979